AVALO THERAPEUTICS, INC. Accrued Royalties, Current
AVALO THERAPEUTICS, INC. (AVTX) had Accrued Royalties, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Royalties, Current $0.00.
- 2026-03-31: Accrued Royalties, Current $327.00K.
- 2025-12-31: Accrued Royalties, Current $327.00K.
- 2025-09-30: Accrued Royalties, Current $327.00K.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $327.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $327.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $327.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $327.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $327.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $327.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $241.00K 10-Q · filed 2024-11-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $214.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $607.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $445.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $508.00K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $399.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $282.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $440.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $375.00K 10-Q · filed 2022-11-07 |
| 2021-09-30 | $653.00K 10-Q · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |